We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Every year MHRA receives requests for its staff to speak at conferences and other events across the world.
This guidance is designed to provide information on the implementation of changes to advertising and promotion of medicines authorised in the UK from 1 January 2025.
How to comply with the regulations when using a medical device differently to the manufacturer's instructions.
Guidance on registration of certain in vitro diagnostic devices reliant on expired or expiring CE certificates or declarations of conformity.
Supplementary information for international regulators on packaging changes and the export of UK medicines.
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
How investigators and sponsors should manage clinical trials during COVID-19
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
Information for people who wish to apply to release a vaccine or a blood product to market in the UK.
Guidance for industry on preparing responses to good laboratory practice (GLP) and good clinical practice (GCP) inspection reports.
How to report adverse incidents involving insulin infusion pumps and integrated meter systems under the vigilance system.
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
This guidance sets out how the MHRA is handling centralised applications that were still pending on 1 January 2021.
The review of the safety of isotretinoin has concluded.
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
Guidance for healthcare establishments that manufacture medical devices in-house.
A summary of actions related to problems with T34 syringe drivers
Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
Guidance for local partnerships on how to review adult drug and alcohol related deaths and near-fatal overdoses to prevent future deaths.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).